Clinical trials
Observational Hematologic Neoplasms trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2015 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Not yet recruiting | 2 |
| Enrolling by invitation | 1 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nottingham University Hospitals NHS Trust | 2 |
| Adaptimmune | 1 |
| Imperial College London | 1 |
| Kiadis Pharma | 1 |
| Kite, A Gilead Company | 1 |
| Princess Maxima Center for Pediatric Oncology | 1 |
| South Tees Hospitals NHS Foundation Trust | 1 |
| The Royal Wolverhampton Hospitals NHS Trust | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Neoplasms | 9 |
| Neoplasms | 3 |
| Autoimmune Diseases | 2 |
| COVID-19 | 1 |
| Graft vs Host Disease | 1 |
| Leukemia | 1 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 |
| Leukemia, Myeloid, Acute | 1 |
| Metabolic Diseases | 1 |
| Myelodysplastic Syndromes | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.